Risklick is a promising startup founded in 2019 with a vision to revolutionize the development of clinical trial protocols using AI. Their slogan "Develop the Clinical Trial Protocols of the Future Using AI" reflects their dedication to leveraging cutting-edge technology for medical innovation. The innovative AI software, Protocol AI, aims to empower experts in conducting faster, cheaper, and safer trials, potentially shaping the future of medical research and development.
There is no investment information
No recent news or press coverage available for Risklick.